While many people in wealthier countries have been vaccinated against COVID-19, there is still a need for vaccination in much of the world. A new vaccine developed at MIT and Beth Israel Deaconess Medical Center may aid in those efforts, offering an inexpensive, easy-to-store, and effective alternative to RNA vaccines.
A possible new COVID-19 vaccine could be accessible for more of the world
March 16, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022